宁心安神方联合西医常规治疗心力衰竭伴利尿剂抵抗临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.6+1

基金项目:


Clinical Study on Ningxin Anshen Recipe Combined with Routine Western Medicine for Heart Failure Complicated with Diuretic Resistance
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察宁心安神方联合西医常规治疗心力衰竭伴利尿剂抵抗的临床疗效。方法:选择86 例心 力衰竭伴利尿剂抵抗患者为研究对象,随机分为对照组和治疗组各43 例。对照组给予盐酸多巴胺注射液、托 拉塞米等西医常规治疗,治疗组在对照组的基础上给予宁心安神方治疗。2 组均治疗2 周。比较2 组临床疗 效、心功能指标[左室舒张末期内径(LVEDd)、左室收缩末期内径(LVESD) 和左室射血分数(LVEF)]、炎 症因子[白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、超敏C-反应蛋白(hs-CRP)]水平变化。结果: 治疗组总有效率为95.35%,高于对照组83.72%,2 组比较,差异有统计学意义(P<0.05)。治疗前,2 组 LVEDd、LVESD、LVEF 水平比较,差异无统计学意义(P>0.05)。治疗后,2 组LVEF 水平均较治疗前上 升(P<0.05),LVEDd、LVESD 水平均较治疗前降低(P<0.05);且治疗组上述3 项指标改善较对照组更显 著(P<0.05)。治疗前,2 组血清IL-6、TNF-α、hs-CRP 水平比较,差异无统计学意义(P>0.5);治疗 后,2 组IL-6、TNF-α、hs-CRP 水平均较治疗前显著降低(P<0.05),且治疗组上述各项指标均低于对照 组(P<0.05)。结论:宁心安神方联合西医常规治疗心力衰竭伴利尿剂抵抗,可抑制患者机体炎症反应,有效 改善心功能,提高临床疗效。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Ningxin Anshen Formula combined with routine western medicine for heart failure complicated with diuretic resistance. Methods: A total of 86 cases of patients with heart failure complicated with diuretic resistance were selected as the study objects and randomly divided into the treatment group and the control group,with 43 cases in each group. The control group was treated with Dopamine Hydrochloride Injection, Tolasemide, and other routine western medicine treatment,and the treatment group was additionally treated with Ningxin Anshen Formula based on the treatment of the control group. Both groups were treated for 2 weeks. The changes in the levels of heart function indexes including left ventricular end diastolic diameter (LVEDd),left ventricular end systolic diameter (LVESD) and left ventricular ejection fraction (LVEF), and inflammatory factors including interleukin-6 (IL-6),tumor necrosis factor-α (TNF-α) and high sensitivity C-reactive protein (hs-CRP),as well as clinical effects were compared between the two groups. Results: The total effective rate was 95.35% in the treatment group, higher than that of 83.72% in the control group, the difference being significant (P<0.05). Before treatment,there was no significant difference being found in the comparison of the levels of LVEDd,LVESD,and LVEF between the two groups (P>0.05). After treatment,the levels of LVEF in the two groups were increased when compared with those before treatment (P<0.05),and the levels of LVEDd and LVESD were decreased when compared with those before treatment (P<0.05);the improvement of the above three indexes in the treatment group was more significant than that in the control group (P<0.05). Before treatment,there was no significant difference being found in the comparison of the levels of IL-6,TNF- α,and hs-CRP between the two groups (P>0.05). After treatment,the levels of IL- 6, TNF- α, and hs- CRP in the two groups were significantly decreased when compared with those before treatment (P<0.05), and the above indexes in the treatment group were lower than those in the control group (P<0.05). Conclusion:Ningxin Anshen Formula combined with routine western medicine for heart failure complicated with diuretic resistance can inhibit the inflammatory responses of the body,and effectively improve heart function of patients and clinical effects.

    参考文献
    相似文献
    引证文献
引用本文

沈昕,杜晓马,陈芳.宁心安神方联合西医常规治疗心力衰竭伴利尿剂抵抗临床研究[J].新中医,2023,55(4):51-54

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-02-24
  • 出版日期:
文章二维码